324 related articles for article (PubMed ID: 28846482)
1. Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay.
Liu X; Guo C; Chowdhury B; Starke P; Limb S; Peri P; Schroeder A; Doub W
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):399-410. PubMed ID: 28846482
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers.
Slator L; von Hollen D; Sandell D; Hatley RH
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S37-43. PubMed ID: 24476047
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of the OptiChamber Diamond valved holding chamber.
Hatley RH; von Hollen D; Sandell D; Slator L
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
[TBL] [Abstract][Full Text] [Related]
4. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler.
Asmus MJ; Liang J; Coowanitwong I; Hochhaus G
Pharmacotherapy; 2004 Feb; 24(2):159-66. PubMed ID: 14998215
[TBL] [Abstract][Full Text] [Related]
5. Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.
Dissanayake S; Nagel M; Falaschetti E; Suggett J
Pulm Pharmacol Ther; 2018 Feb; 48():179-184. PubMed ID: 29024795
[TBL] [Abstract][Full Text] [Related]
6. In vitro and clinical characterization of the valved holding chamber AeroChamber Plus
Wachtel H; Nagel M; Engel M; El Azzi G; Sharma A; Suggett J
Respir Med; 2018 Apr; 137():181-190. PubMed ID: 29605203
[TBL] [Abstract][Full Text] [Related]
7. Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices.
Sandell D; Mitchell JP
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):156-81. PubMed ID: 25089555
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of Valved Holding Chambers Simulating Repurposing Use of Ciclesonide Metered-dose Inhaler by Patients with Pneumonia].
Yoshida H; Abe Y; Usui A; Izutsu KI
Yakugaku Zasshi; 2020 Dec; 140(12):1495-1500. PubMed ID: 32981902
[TBL] [Abstract][Full Text] [Related]
10. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers.
Asmus MJ; Liang J; Coowanitwong I; Vafadari R; Hochhaus G
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):204-8. PubMed ID: 11868926
[TBL] [Abstract][Full Text] [Related]
11. A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.
Dissanayake S; Suggett J
Ther Adv Respir Dis; 2018; 12():1753465817751346. PubMed ID: 29378477
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Disposable and Traditional Accessory Devices for Use With a Pressurized Metered-Dose Inhaler.
Saeed H; Abdelrahim ME; Rabea H; Salem HF
Respir Care; 2020 Mar; 65(3):320-325. PubMed ID: 31455686
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant test methods to establish in vitro equivalence for spacers and valved holding chambers used with pressurized metered dose inhalers (pMDIs).
Mitchell J; Dolovich MB
J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):217-42. PubMed ID: 22857273
[TBL] [Abstract][Full Text] [Related]
14. Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks.
Xu Z; Hsu W; von Hollen D; Viswanath A; Nikander K; Dalby R
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S44-54. PubMed ID: 24219816
[TBL] [Abstract][Full Text] [Related]
15. Drug Delivery in Asthmatic Children Following Coordinated and Uncoordinated Inhalation Maneuvers: A Randomized Crossover Trial.
Berlinski A; von Hollen D; Hatley RHM; Hardaker LEA; Nikander K
J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):182-189. PubMed ID: 27977309
[TBL] [Abstract][Full Text] [Related]
16. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered-dose inhaler.
Asmus MJ; Coowanitwong I; Kwon SH; Khorsand N; Hochhaus G
Pharmacotherapy; 2003 Dec; 23(12):1538-44. PubMed ID: 14695033
[TBL] [Abstract][Full Text] [Related]
17. Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler.
Qaqish R; Berlinski A
Respir Care; 2021 Aug; 66(8):1315-1322. PubMed ID: 34103384
[TBL] [Abstract][Full Text] [Related]
18. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
Berlinski A; Pennington D
Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
[TBL] [Abstract][Full Text] [Related]
19. Spacers and Valved Holding Chambers-The Risk of Switching to Different Chambers.
Lavorini F; Barreto C; van Boven JFM; Carroll W; Conway J; Costello RW; Dahl BH; Dekhuijzen RPN; Holmes S; Levy M; Molimard M; Roche N; Román-Rodriguez M; Scichilone N; Scullion J; Usmani OS
J Allergy Clin Immunol Pract; 2020 May; 8(5):1569-1573. PubMed ID: 31927099
[TBL] [Abstract][Full Text] [Related]
20. The evolution of spacers and valved holding chambers.
Nikander K; Nicholls C; Denyer J; Pritchard J
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S4-23. PubMed ID: 25054481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
